ATI Inc.
ATI
(New York Stock Exchange)

Recent

price

57.15

P/E

ratio

21.81

div

yld

- -

ROIC.AI

Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.
Similar Companies
Business
ATI Inc. manufactures and sells specialty materials and components worldwide. The company operates in two segments: High Performance Materials & Components (HPMC) and Advanced Alloys & Solutions (AA&S). The HPMC segment produces various materials, including titanium and titanium-based alloys, nickel- and cobalt-based alloys and superalloys, advanced powder alloys and other specialty materials, in long product forms, such as ingot, billet, bar, rod, wire, shapes and rectangles, and seamless tubes, as well as precision forgings, components, and machined parts. The segment serves aerospace and defense, medical, and energy markets. The AA&S segment produces zirconium and related alloys, including hafnium and niobium, nickel-based alloys, titanium and titanium-based alloys, and specialty alloys in a variety of forms, such as plate, sheet, and precision rolled strip products. It also provides hot-rolling conversion services, including carbon steel products, and titanium products. This segment offers its solutions to the energy, aerospace and defense, automotive, and electronics markets. The company was formerly known as Allegheny Technologies Incorporated. ATI Inc. was founded in 1960 and is headquartered in Dallas, Texas.

Company News

  • ATI announces sale of precision rolled strip operations to Ulbrich

  • ATI Physical Therapy Reports Third Quarter 2024 Results

  • Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission

  • ATI's Earnings Miss Estimates in Q3, Revenues Increase Y/Y

  • ATI Inc (ATI) Q3 2024 Earnings Call Transcript

  • Allegheny Technologies (ATI) Q3 Earnings and Revenues Lag Estimates

  • ATI Announces Third Quarter 2024 Results

  • Allegheny Technologies (ATI) Reports Next Week: Wall Street Expects Earnings Growth

  • ATI Physical Therapy to Announce Third Quarter 2024 Financial Results

  • Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek™ 2024

  • Allegheny Technologies (ATI) Exceeds Market Returns: Some Facts to Consider

  • See Democracy in Action: Allegheny County High Schools Conduct Voter Registration Drives This Week

  • Allegheny Technologies (ATI) Stock Declines While Market Improves: Some Information for Investors

  • Allegheny Technologies (ATI) Stock Sinks As Market Gains: Here's Why

  • ATI Announces Webcast for Third Quarter 2024 Results

  • Allegheny Technologies (ATI) Stock Dips While Market Gains: Key Facts

  • Allegheny Technologies (ATI) Declines More Than Market: Some Information for Investors

  • Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment of Moderate to Severe Atopic Dermatitis

  • Allegheny Technologies (ATI) Stock Falls Amid Market Uptick: What Investors Need to Know

  • Why Is Allegheny Technologies (ATI) Up 0.7% Since Last Earnings Report?